Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.
about
The role of microRNAs in bladder cancerExpression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedureElevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2Identification of a circulating microRNA signature for colorectal cancer detection.Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma.MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal AdenocarcinomaMicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5.Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2.Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinomaMiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.The diverse role of miR-31 in regulating cancer associated phenotypes.UPF1 helicase promotes TSN-mediated miRNA decay.Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?MicroRNA-31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1.Decreased expression of LncRNA MIR31HG in human bladder cancer.Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.Single-Molecule Localization Microscopy allows for the analysis of cancer metastasis-specific miRNA distribution on the nanoscale.MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis.Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study.miR-31 functions as an oncogene in cervical cancer.miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.Role of Non-Coding RNAs in the Etiology of Bladder Cancer.miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer.Increased miR-141 expression is associated with diagnosis and favorable prognosis of patients with bladder cancer.
P2860
Q26744149-A8102ECC-CF9A-4261-B587-2130C35F5207Q33364071-ACDA0DBF-7931-4B89-9FF9-78A3E2AB3B1EQ33689126-15034B9B-6AAA-4C22-86A6-A6149DC152D1Q35081153-16E38876-05A9-4F40-AC34-41CF31E668F4Q35141718-329970FD-B828-493F-8C41-DB3522FEF692Q35550204-029DE0CD-6758-4386-97E7-32C78C023D9AQ35852437-CD250A92-5884-4B26-8CC0-093CA9EB447BQ37317285-53D82E0A-B706-4D70-9392-32535A66122DQ37392777-CFA42B44-72C7-4497-B1D2-8A63B14DEE50Q37527769-E9959707-572D-40DD-9B3B-D8DD60079EDCQ37696266-5991D9ED-462D-4177-BA75-5FF3549713FDQ38133768-0F0A98F5-0724-4D0F-BB68-B74D7AC0896BQ38615446-2A8A49EF-7923-4A08-946C-CF90CC9775BFQ38667456-8A9C9EC5-E05F-4426-AE3F-10F69B8450C8Q38705662-0C103EFD-19EF-453A-A340-6BE6974C6DA9Q38756975-A6EF687B-760E-46C3-BBB8-9B890CD45585Q38806672-0028691C-08F9-48EA-882C-57432CF4D651Q38820011-1978FCBC-0117-4710-9766-98744128C6CAQ39440371-EA5702AD-1AC1-4A2B-B4BE-9AE9DD0713C0Q40160548-D5468965-2ADE-4A43-BE39-8CDC70216610Q41612865-AA71A20A-4EA1-4A4D-ACC1-526FB578130FQ42146975-68F77C5C-2E15-4FD7-A978-F26018AD0EE1Q42373335-656E37AB-DD70-4B3D-BA91-1BB3F334BA5FQ46236214-A3D4352C-7250-46A7-B1C7-D66584295293Q47119023-DF3FCF0C-DDF5-4F09-A099-5930176EBE30Q50448025-EC2AE80A-4A2C-4A83-96D4-5E4EA05A0B9B
P2860
Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Decreased expression of microR ...... patients with bladder cancer.
@en
Decreased expression of microR ...... patients with bladder cancer.
@nl
type
label
Decreased expression of microR ...... patients with bladder cancer.
@en
Decreased expression of microR ...... patients with bladder cancer.
@nl
prefLabel
Decreased expression of microR ...... patients with bladder cancer.
@en
Decreased expression of microR ...... patients with bladder cancer.
@nl
P2093
P2860
P1476
Decreased expression of microR ...... patients with bladder cancer.
@en
P2093
P2860
P2888
P304
P356
10.1007/S12094-013-1014-4
P577
2013-02-14T00:00:00Z